Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial60

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial11

Views

Views
May 20250
June 20253
July 20257
August 20250
September 20250
October 20250
November 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil5
Singapore3
United States2
Ethiopia1
 

Top cities views

Views
Chicago1
Formiga1
Passo Fundo1
Paulo Afonso1
São José de Ribamar1
São José do Rio Preto1